insights_auto
Why is 600535 up 2.22%?
Dive Deeperchevron_right
600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥ 14.28
arrow_upward
+2.22%(+0.31) 1D
10-р сарын 14, 15:00:01 (GMT+8) · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CN¥ 14.00
High
CN¥ 14.31
Low
CN¥ 13.93
Mkt. cap
20.87 тэрбум
Avg. vol.
11.81 сая
Volume
15.47 сая
Dividend
2.38%
Quarterly dividend
CN¥ 0.09
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
17.44
52-wk high
CN¥ 16.24
52-wk low
CN¥ 12.90
EPS
CN¥ 0.82
Shares outstanding
1.51 тэрбум
No. of employees
11 мян
Open
CN¥ 14.00
High
CN¥ 14.31
Low
CN¥ 13.93
Mkt. cap
20.87 тэрбум
Avg. vol.
11.81 сая
Volume
15.47 сая
Dividend
2.38%
Quarterly dividend
CN¥ 0.09
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
17.44
52-wk high
CN¥ 16.24
52-wk low
CN¥ 12.90
EPS
CN¥ 0.82
Shares outstanding
1.51 тэрбум
No. of employees
11 мян
Related stocks
News stories
From web sources and news partners
Yahoo
·
33 минутын өмнө
Dow closes in the red after report finds inflation rose in September
GlobeNewswire
·
1 цагийн өмнө
RedCloud Receives Expected Nasdaq Staff Delisting
Simply Wall Street
·
23 минутын өмнө
Honeywell International (HON) Debuts Forge Cognition For Facility Operations
Investor's Business Daily
·
1 цагийн өмнө
Nasdaq, Small Caps Hit On AI Worries, Pesky Inflation: Dell, GILD, THC In Focus
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd